Potential for lead-time and length-time biases in outcomes in esophageal adenocarcinoma

Am J Gastroenterol. 2009 Dec;104(12):3106-7; author reply 3107-8. doi: 10.1038/ajg.2009.488.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adenocarcinoma / diagnosis*
  • Adenocarcinoma / epidemiology
  • Aged
  • Aged, 80 and over
  • Combined Modality Therapy
  • Diagnosis, Differential
  • Endoscopy, Gastrointestinal / methods*
  • Esophageal Neoplasms / diagnosis*
  • Esophageal Neoplasms / epidemiology
  • Esophageal Neoplasms / therapy
  • Female
  • Humans
  • Incidence
  • Male
  • Neoplasm Staging / methods
  • Prognosis
  • Risk Factors
  • SEER Program / trends*
  • Survival Rate / trends
  • Time Factors
  • United States / epidemiology